United Therapeutics | Passifs Courants



Current Liabilities Changement Date
Amarin USD 201.55M 28.99M 2024-09
Ardelyx USD 77.83M 7.33M 2024-12
Baxter International USD 6.51B 311M 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Biogen USD 5.53B 103.8M 2024-12
BioMarin Pharmaceutical USD 606.99M 108.67M 2024-12
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
Insmed USD 297.53M 38.34M 2024-12
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
J&J USD 56.9B 6.58B 2025-03
Moderna USD 1.6B 602M 2025-03
Pfizer USD 43B 216M 2024-12
PTC Therapeutics USD 580.98M 29.73M 2024-12
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Sarepta Therapeutics USD 731.68M 32.2M 2024-12
Teva Pharmaceutical Industries USD 12.8B 1B 2024-12
United Therapeutics USD 721.5M 16.6M 2025-03
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



United Therapeutics Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.